Session Title:
Challenges and Controversies in Barrett’s Esophagus

Date: May 21, 2019 Time: 2:15 – 2:30 p.m.
Location: SDCC Room 33ABC
View our full press release related to this independent study validation here


*Digestive Disease Week® and DDW® are registered trademarks of the DDW LLC

Barrett's Esophagus & Esophageal Cancer

Three million people in the U.S. have Barrett's Esophagus, a known precursor to esophageal cancer. Until now, identifying which patients are at greatest risk for esophageal cancer has been impossible. Cernostics is looking to change that… Learn how
View All News
Blinded Independent Validation Study of Tissue Systems Pathology Test in Determining Risk of Progression to Esophageal Cancer in Patients with Barrett’s Esophagus to be Presented at DDW 2019... Read More
Cernostics Secures Additional Patents for Proprietary Barrett’s Esophagus Clinical Diagnostics... Read More
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures... Read More
01/09/2017 San Francisco, CA
JP Morgan Healthcare Conference
05/06/2017 Chicago, IL
Digestive Disease Week
10/13/2017 Orlando, FL
American College of Gastroenterology
Customer Service

Mon-Fri 9am-5pm (EST)